ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Institutional investor · Portfolio as of Q4 2018

SEC EDGAR SourceSEC Filings

Top Holdings1,320 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

VISA INC-CLASS A SHARES

6M$785.4M2.1%$124.910.00%
1 qtr
New
82

HOME DEPOT INC

4.6M$782.7M2.1%$143.320.00%
1 qtr
New
82

BRISTOL-MYERS SQUIBB CO

14.8M$767.5M2.0%$38.860.00%
1 qtr
New
82

MASTERCARD INC - A

4M$760.9M2.0%$178.730.00%
1 qtr
New
72
EWYEWY
ETF

ISHARES MSCI SOUTH KOREA ETF

11.2M$661.7M1.7%$51.750.00%
1 qtr
New
72

ABBVIE INC

7.1M$658.6M1.7%$66.470.00%
1 qtr
New
72

TJX COMPANIES INC

14.4M$642.2M1.7%$40.340.00%
1 qtr
New
72

MICROSOFT CORP

5.7M$583.5M1.5%$93.930.00%
1 qtr
New
72

ADOBE INC

2.5M$569.3M1.5%$226.240.00%
1 qtr
New
72

HCA HOLDINGS INC

4.1M$506.6M1.3%$115.240.00%
1 qtr
New
72

MERCK & CO. INC.

6.1M$466M1.2%$57.900.00%
1 qtr
New
71
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

12.6M$463.3M1.2%$31.770.00%
1 qtr
New
71

BIOGEN IDEC INC

1.5M$458.6M1.2%$293.520.00%
1 qtr
New
71
AZNAZN
ADR

ASTRAZENECA PLC

11.7M$444.6M1.2%$61.500.00%
1 qtr
New
71

INTEL CORP

9M$423.9M1.1%$40.230.00%
1 qtr
New
71

UNITEDHEALTH GROUP INC

1.7M$422.2M1.1%$219.580.00%
1 qtr
New
71
SHSHPGDelisted
ADR

SHIRE PLC

2.4M$417.1M1.1%$173.00
1 qtr
New
71
CELGCELGDelisted

CELGENE CORP

5.6M$361.4M0.9%
1 qtr
New
61

AUTOMATIC DATA PROCESSING

2.7M$359.5M0.9%$111.430.00%
1 qtr
New
61

INTL BUSINESS MACHINES CORP

3.2M$359.4M0.9%$78.510.00%
1 qtr
New
61
$38.2B
AUM
1,320
Positions
Q4 2018
Filing
Rating · 3.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q4'18
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg <1 quarter
<1Q97%1-4Q0%1-2Y0%2Y+3%

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP manages $38.2B across 1320 positions as of Q4 2018. Top holdings: V (2.1%), HD (2.1%), BMY (2.0%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3/5.0.

Q4 2018 Summary

Active quarter - 1320 new positions, 0 exits, 0 increased. Top move: V (NEW, conviction 82). Portfolio: $38.2B across 1320 positions.

Top holdings by portfolio weight

Total AUM$38B
V2.06%
HD2.05%
BMY2.01%
MA1.99%
EWY1.73%
ABBV1.73%
TJX1.68%
MSFT1.53%
ADBE1.49%
HCA1.33%
Other1.22%

Portfolio allocation by GICS sector

Sectors11
Healthcare18.42%
Financial Services17.89%
Technology16.94%
Unknown13.35%
Consumer Cyclical11.31%
Industrials5.53%
Communication Services4.82%
Consumer Defensive4.03%
Basic Materials3.53%
Real Estate1.47%
Other2.69%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Financial Services, Technology
Compare DNA across all funds
7-dimension quality assessment
Solid(3.0 / 5.0)
Track Record56
Conviction45
Concentration42
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
ADSKADSKAUTODESK INC
Q3 2024 Q2 2026+2.4M shares+$642.5M
8Q
DHRDHRDANAHER CORP
Q3 2024 Q2 2026+5.1M shares+$983.4M
8Q
INTUINTUINTUIT INC
Q3 2024 Q2 2026+3.9M shares+$1.2B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used